Repeated unilateral injections of botulinum toxin in masticatory muscles in adult rats do not amplify condylar and alveolar bone loss nor modify the volume of the hypertrophic bone proliferation at enthesis.
Abstract
[OBJECTIVES] Botulinum toxin is used in human in repeatedly masticatory muscles injections. A single BTX injection in animal induces mandibular bone loss with a muscle enthesis hypertrophic metaplasia. Our aim was to evaluate mandibular bone changes after unilateral repeated injections of BTX in adult rats.
[STUDY DESIGN] Mature male rats were randomized into 3 groups: one, two or three injections. Each rat received injections in right masseter and temporalis muscles. The left side was the control side. Microcomputed tomography was used to perform 2D and 3D analyses.
[RESULTS] Bone loss was evidenced on the right sides of alveolar and condylar bone. Alveolar bone volume increased in both control left side and injected right side whereas condylar bone volume remained constant in all groups, for both sides. Enthesis bone hypertrophic metaplasias were evidenced on the BTX injected sides without any modification with the number of injections.
[CONCLUSION] BTX repeated injections in masticatory muscles lead to major mandibular condylar and alveolar bone loss that does not worsen. They lead to the occurrence of an enthesis bone proliferation that is not dependent on the number of injections. These results are an argument for the safety of BTX injections in masticatory muscles in human.
[STUDY DESIGN] Mature male rats were randomized into 3 groups: one, two or three injections. Each rat received injections in right masseter and temporalis muscles. The left side was the control side. Microcomputed tomography was used to perform 2D and 3D analyses.
[RESULTS] Bone loss was evidenced on the right sides of alveolar and condylar bone. Alveolar bone volume increased in both control left side and injected right side whereas condylar bone volume remained constant in all groups, for both sides. Enthesis bone hypertrophic metaplasias were evidenced on the BTX injected sides without any modification with the number of injections.
[CONCLUSION] BTX repeated injections in masticatory muscles lead to major mandibular condylar and alveolar bone loss that does not worsen. They lead to the occurrence of an enthesis bone proliferation that is not dependent on the number of injections. These results are an argument for the safety of BTX injections in masticatory muscles in human.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 2 | |
| 해부 | condylar
|
scispacy | 1 | ||
| 해부 | alveolar bone
|
scispacy | 1 | ||
| 해부 | bone
|
scispacy | 1 | ||
| 해부 | masticatory muscles
|
scispacy | 1 | ||
| 해부 | mandibular bone
|
scispacy | 1 | ||
| 해부 | muscle
|
scispacy | 1 | ||
| 해부 | masseter
|
scispacy | 1 | ||
| 해부 | temporalis muscles
|
scispacy | 1 | ||
| 해부 | alveolar
|
scispacy | 1 | ||
| 해부 | condylar bone
|
scispacy | 1 | ||
| 합병증 | masticatory muscles
|
scispacy | 1 | ||
| 합병증 | enthesis
|
scispacy | 1 | ||
| 약물 | [OBJECTIVES] Botulinum toxin
|
scispacy | 1 | ||
| 질환 | bone loss
|
C0029453
Osteopenia
|
scispacy | 1 | |
| 질환 | muscle enthesis hypertrophic metaplasia
|
scispacy | 1 | ||
| 질환 | bone hypertrophic metaplasias
|
scispacy | 1 | ||
| 질환 | metaplasia
|
scispacy | 1 | ||
| 기타 | rats
|
scispacy | 1 | ||
| 기타 | human
|
scispacy | 1 | ||
| 기타 | BTX
|
scispacy | 1 | ||
| 기타 | rat
|
scispacy | 1 | ||
| 기타 | Alveolar bone
|
scispacy | 1 | ||
| 기타 | condylar bone
|
scispacy | 1 | ||
| 기타 | bone hypertrophic metaplasias
|
scispacy | 1 | ||
| 기타 | mandibular condylar
|
scispacy | 1 |
MeSH Terms
Animals; Rats; Male; Alveolar Bone Loss; Mandibular Condyle; X-Ray Microtomography; Injections, Intramuscular; Random Allocation; Masticatory Muscles; Rats, Wistar; Botulinum Toxins, Type A; Botulinum Toxins; Masseter Muscle; Hypertrophy
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.